Small-Molecule Drugs
Minoxidil
Last reviewed: 2026-11-19
Overview
A small-molecule drug with distinct cardiovascular and dermatologic approved products.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Rogaine · Hair Loss
Regrowth of hair in the product-specific labeled adult male or female pattern-hair-loss population; not an approval of all minoxidil forms for this use.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextEvidence at a glance
Product-specific approvals do not imply that one formulation is approved for another formulation’s indication.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Omeprazole
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications